Export

Polymyxin B (injection)
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.3. Reserve group antibiotics
ATC codes: J01XB02
EMLc
Indication
Carbapenem resistant Acinetobacter baumannii ICD11 code: MG50.02
INN
Polymyxin B
Medicine type
Chemical agent
Antibiotic groups
RESERVE
List type
Complementary
Formulations
Parenteral > General injections > unspecified: 500000 IU in vial powder for injection (equivalent to 50 mg polymyxin B base)
EML status history
First added in 2019 (TRS 1021)
Changed in 2023 (TRS 1049)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Polymyxin B (injection)
DrugBank
Polymyxin b (Polymyxin B Sulfate)
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the listing for polymyxin B on the EML and EMLc be amended to include also the equivalent strength in mg of polymyxin B base.